THE HEALTHCARE SECTOR IN SINGAPORE
Singapore is known for its state-of-the-art medical facilities and services, especially in the ASEAN region. The population stands at around 5.7 million (2019), of which 886,00 are aged 65 and above, projected to reach 900,000 by 2030. The country is a key location for pharmaceutical and HealthTech companies. 
Webinar recorded July 22,2020
3x
€37 billion
8
Pharmaceutical sector manufacturing output produced since 2000. In 2016, the sector produced more than S$16 billion worth of products for global markets.
Projected healthcare expenditure in Singapore by 2030, at a CAGR of 5.9%

of the top 10 pharmaceutical companies have facilities in Singapore, manufacturing 4 of the top 10 drugs by global revenue.

UK EXPERTISE
SINGAPORE ECOSYSTEM
The UK has more medical products in development than any other country in Europe. UK researchers and institutions have pioneered major scientific breakthroughs – from the discovery of penicillin and the structure of DNA to advancements in neuroscience and medical imaging, and developments in stem cells and in vitro fertilisation.
As a leading biomedical sciences hub at the heart of Asia, Singapore is the choice location for companies to develop and produce new products that better meet Asia’s healthcare needs. Companies benefit from a pro-business environment, infrastructure, talent and innovation ecosystem, as well as the proximity to the rest of Asia. 
INTERESTED IN SCOPING THE SINGAPORE HEALTHCARE MARKET FOR YOUR UK BUSINESS?
HOW WE CAN HELP
OUR HEALTHCARE & LIFE SCIENCES COMMITTEE

The Healthcare and Life Sciences Committee's mission is defined as providing a high-impact, cross-industry platform for members by:

  • Supporting and improving market access for healthcare firms looking to operate in SE Asia;
  • Being an authoritative and respected voice, which responds effectively to consultations on changing regulations and health reform, and proactively leads advocacy on key themes;
  • Evolving new models of care by creating collaboration opportunities across the sector;
  • Supporting consortium development between members on projects, opportunities and initiatives in SEA,
  • Improving cross-sector knowledge sharing, and consortium development between members on projects, opportunities and initiatives in SE Asia.